Cargando…

Imaging Evaluation of Pulmonary and Non-Ischaemic Cardiovascular Manifestations of COVID-19

Coronavirus Disease 2019 (COVID-19) has been a pandemic challenge for the last year. Cardiovascular disease is the most described comorbidity in COVID-19 patients, and it is related to the disease severity and progression. COVID-19 induces direct damage on cardiovascular system, leading to arrhythmi...

Descripción completa

Detalles Bibliográficos
Autores principales: Cicco, Sebastiano, Vacca, Antonio, Cariddi, Christel, Carella, Rossella, Altamura, Gianluca, Solimando, Antonio Giovanni, Lauletta, Gianfranco, Pappagallo, Fabrizio, Cirulli, Anna, Stragapede, Assunta, Susca, Nicola, Grasso, Salvatore, Ria, Roberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8304239/
https://www.ncbi.nlm.nih.gov/pubmed/34359355
http://dx.doi.org/10.3390/diagnostics11071271
_version_ 1783727286027026432
author Cicco, Sebastiano
Vacca, Antonio
Cariddi, Christel
Carella, Rossella
Altamura, Gianluca
Solimando, Antonio Giovanni
Lauletta, Gianfranco
Pappagallo, Fabrizio
Cirulli, Anna
Stragapede, Assunta
Susca, Nicola
Grasso, Salvatore
Ria, Roberto
author_facet Cicco, Sebastiano
Vacca, Antonio
Cariddi, Christel
Carella, Rossella
Altamura, Gianluca
Solimando, Antonio Giovanni
Lauletta, Gianfranco
Pappagallo, Fabrizio
Cirulli, Anna
Stragapede, Assunta
Susca, Nicola
Grasso, Salvatore
Ria, Roberto
author_sort Cicco, Sebastiano
collection PubMed
description Coronavirus Disease 2019 (COVID-19) has been a pandemic challenge for the last year. Cardiovascular disease is the most described comorbidity in COVID-19 patients, and it is related to the disease severity and progression. COVID-19 induces direct damage on cardiovascular system, leading to arrhythmias and myocarditis, and indirect damage due to endothelial dysfunction and systemic inflammation with a high inflammatory burden. Indirect damage leads to myocarditis, coagulation abnormalities and venous thromboembolism, Takotsubo cardiomyopathy, Kawasaki-like disease and multisystem inflammatory syndrome in children. Imaging can support the management, assessment and prognostic evaluation of these patients. Ultrasound is the most reliable and easy to use in emergency setting and in the ICU as a first approach. The focused approach is useful in management of these patients due its ability to obtain quick and focused results. This tool is useful to evaluate cardiovascular disease and its interplay with lungs. However, a detailed echocardiography evaluation is necessary in a complete assessment of cardiovascular involvement. Computerized tomography is highly sensitive, but it might not always be available. Cardiovascular magnetic resonance and nuclear imaging may be helpful to evaluate COVID-19-related myocardial injury, but further studies are needed. This review deals with different modalities of imaging evaluation in the management of cardiovascular non-ischaemic manifestations of COVID-19, comparing their use in emergency and in intensive care.
format Online
Article
Text
id pubmed-8304239
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-83042392021-07-25 Imaging Evaluation of Pulmonary and Non-Ischaemic Cardiovascular Manifestations of COVID-19 Cicco, Sebastiano Vacca, Antonio Cariddi, Christel Carella, Rossella Altamura, Gianluca Solimando, Antonio Giovanni Lauletta, Gianfranco Pappagallo, Fabrizio Cirulli, Anna Stragapede, Assunta Susca, Nicola Grasso, Salvatore Ria, Roberto Diagnostics (Basel) Review Coronavirus Disease 2019 (COVID-19) has been a pandemic challenge for the last year. Cardiovascular disease is the most described comorbidity in COVID-19 patients, and it is related to the disease severity and progression. COVID-19 induces direct damage on cardiovascular system, leading to arrhythmias and myocarditis, and indirect damage due to endothelial dysfunction and systemic inflammation with a high inflammatory burden. Indirect damage leads to myocarditis, coagulation abnormalities and venous thromboembolism, Takotsubo cardiomyopathy, Kawasaki-like disease and multisystem inflammatory syndrome in children. Imaging can support the management, assessment and prognostic evaluation of these patients. Ultrasound is the most reliable and easy to use in emergency setting and in the ICU as a first approach. The focused approach is useful in management of these patients due its ability to obtain quick and focused results. This tool is useful to evaluate cardiovascular disease and its interplay with lungs. However, a detailed echocardiography evaluation is necessary in a complete assessment of cardiovascular involvement. Computerized tomography is highly sensitive, but it might not always be available. Cardiovascular magnetic resonance and nuclear imaging may be helpful to evaluate COVID-19-related myocardial injury, but further studies are needed. This review deals with different modalities of imaging evaluation in the management of cardiovascular non-ischaemic manifestations of COVID-19, comparing their use in emergency and in intensive care. MDPI 2021-07-15 /pmc/articles/PMC8304239/ /pubmed/34359355 http://dx.doi.org/10.3390/diagnostics11071271 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Cicco, Sebastiano
Vacca, Antonio
Cariddi, Christel
Carella, Rossella
Altamura, Gianluca
Solimando, Antonio Giovanni
Lauletta, Gianfranco
Pappagallo, Fabrizio
Cirulli, Anna
Stragapede, Assunta
Susca, Nicola
Grasso, Salvatore
Ria, Roberto
Imaging Evaluation of Pulmonary and Non-Ischaemic Cardiovascular Manifestations of COVID-19
title Imaging Evaluation of Pulmonary and Non-Ischaemic Cardiovascular Manifestations of COVID-19
title_full Imaging Evaluation of Pulmonary and Non-Ischaemic Cardiovascular Manifestations of COVID-19
title_fullStr Imaging Evaluation of Pulmonary and Non-Ischaemic Cardiovascular Manifestations of COVID-19
title_full_unstemmed Imaging Evaluation of Pulmonary and Non-Ischaemic Cardiovascular Manifestations of COVID-19
title_short Imaging Evaluation of Pulmonary and Non-Ischaemic Cardiovascular Manifestations of COVID-19
title_sort imaging evaluation of pulmonary and non-ischaemic cardiovascular manifestations of covid-19
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8304239/
https://www.ncbi.nlm.nih.gov/pubmed/34359355
http://dx.doi.org/10.3390/diagnostics11071271
work_keys_str_mv AT ciccosebastiano imagingevaluationofpulmonaryandnonischaemiccardiovascularmanifestationsofcovid19
AT vaccaantonio imagingevaluationofpulmonaryandnonischaemiccardiovascularmanifestationsofcovid19
AT cariddichristel imagingevaluationofpulmonaryandnonischaemiccardiovascularmanifestationsofcovid19
AT carellarossella imagingevaluationofpulmonaryandnonischaemiccardiovascularmanifestationsofcovid19
AT altamuragianluca imagingevaluationofpulmonaryandnonischaemiccardiovascularmanifestationsofcovid19
AT solimandoantoniogiovanni imagingevaluationofpulmonaryandnonischaemiccardiovascularmanifestationsofcovid19
AT laulettagianfranco imagingevaluationofpulmonaryandnonischaemiccardiovascularmanifestationsofcovid19
AT pappagallofabrizio imagingevaluationofpulmonaryandnonischaemiccardiovascularmanifestationsofcovid19
AT cirullianna imagingevaluationofpulmonaryandnonischaemiccardiovascularmanifestationsofcovid19
AT stragapedeassunta imagingevaluationofpulmonaryandnonischaemiccardiovascularmanifestationsofcovid19
AT suscanicola imagingevaluationofpulmonaryandnonischaemiccardiovascularmanifestationsofcovid19
AT grassosalvatore imagingevaluationofpulmonaryandnonischaemiccardiovascularmanifestationsofcovid19
AT riaroberto imagingevaluationofpulmonaryandnonischaemiccardiovascularmanifestationsofcovid19